The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development

Expert Rev Vaccines. 2023 Jan-Dec;22(1):918-920. doi: 10.1080/14760584.2023.2270596. Epub 2023 Oct 19.

Authors

Peter D Skidmore¹, Rocio Canals², Maheshi N Ramasamy³

Affiliations

¹ Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK.
² GSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
³ Oxford Vaccine Group, University of Oxford, NIHR Oxford Biomedical Research Centre, and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

PMID: 37824701
DOI: 10.1080/14760584.2023.2270596

No abstract available

Keywords: Invasive non-typhoidal Salmonellosis; Salmonella Enteritidis; Salmonella Typhimurium; Vaccine.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Salmonella Vaccines*

Substances

Salmonella Vaccines
glyceryl methyl methacrylate